biopharmaceutical

• 

  Court denies AstraZeneca’s bid to block generic Seroquel

  By Julie Beck  |  March 26, 2012

  A district court denied biopharmaceutical company AstraZeneca’s request for a preliminary injunction that would delay generic versions of its anti-psychotic drug Seroquel from entering the market.

• Extended interview: Sandra Leung, GC of Bristol-Myers Squibb

  By Ashley Post  |  December 1, 2011

  Leung talks in-depth about her position at the biopharmaceutical company.

• 

  GC Sandra Leung forms connections within the Bristol-Myers Squibb legal department

  By Ashley Post  |  December 1, 2011

  Leung is proudest of working with management to guide the company through past crises.

• Inside Experts: The next wave of transparency for biopharmaceutical companies

  By Matt Allegrucci  |  September 16, 2011

  When Congress passed the health care reform legislation in 2010, it included the Physician Payments Sunshine Act, which requires biopharmaceutical manufacturers to report (and make public) annual payments made to physicians